Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Epic American Credit and Bond Bubble Laboratory -- Ignore unavailable to you. Want to Upgrade?

To: GraceZ who wrote (52296)	2/1/2006 1:52:45 PM
From: NOW	Read Replies (1) \| Respond to of 110194

well both are examples of products coming to niche markets which may benefit select subgroups of patients (though frankly the research on both, though promising, is clearly early and merits scrutiny). And this does provide a challenge to providing patients who want the absolute state of the art ...however neither of htese is buried, and if they are indeed proven to be significant advances. they will be paid for...assuming that the republican majority doesnt totally strangle funding for medicare and medicaid and waste it on bogus giveaways tpo HMOs and big Pharma like the recent part d